GT
VCYT icon

Glenmede Trust’s Veracyte VCYT Stock Holding History

Glenmede Trust’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-377
Closed -$10K – 2625
2020
Q1 		$10K Hold
377
– – ﹤0.01% 2438
2019
Q4 		$10K Buy
+377
New +$9.76K ﹤0.01% 2438
2019
Q3 		– Sell
-49
Closed -$1 – 3132
2019
Q2 		$1 Hold
49
– – ﹤0.01% 2991
2019
Q1 		$1 Buy
+49
New +$936 ﹤0.01% 2969

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Glenmede Trust's VCYT Position: Q2 2020 in Review

Glenmede Trust sold out of Veracyte (VCYT) in Q2 2020, closing a stake of 377 shares — an estimated $10K sold.

Glenmede Trust first reported a position in VCYT in Q1 2019 and held it in 4 quarters. The position peaked at $10K in Q1 2020. 166 funds tracked by Wall St. Rank hold VCYT as of Q2 2020.

  • Glenmede Trust reported no remaining Veracyte position as of Q2 2020 after selling out during the quarter.
  • Glenmede Trust sold 377 Veracyte shares in Q2 2020, an estimated $10K.
  • Glenmede Trust first reported a position in Veracyte in Q1 2019 and held it in 4 quarters.
  • Glenmede Trust's Veracyte position peaked at $10K in Q1 2020.
  • 166 funds tracked by Wall St. Rank held Veracyte as of Q2 2020.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.